Nwam LLC boosted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 17.1% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 10,065 shares of the medical equipment provider’s stock after buying an additional 1,473 shares during the quarter. Nwam LLC’s holdings in Intuitive Surgical were worth $4,640,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds have also recently made changes to their positions in ISRG. Holos Integrated Wealth LLC bought a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $25,000. Newbridge Financial Services Group Inc. grew its stake in Intuitive Surgical by 300.0% in the 4th quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 33 shares in the last quarter. Olistico Wealth LLC purchased a new position in Intuitive Surgical in the 4th quarter valued at approximately $28,000. Laurel Wealth Advisors LLC bought a new stake in Intuitive Surgical during the 4th quarter valued at $31,000. Finally, Vermillion Wealth Management Inc. raised its holdings in Intuitive Surgical by 58.1% during the 1st quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider’s stock valued at $31,000 after acquiring an additional 25 shares during the period. 83.64% of the stock is currently owned by institutional investors.
Insider Transactions at Intuitive Surgical
In other Intuitive Surgical news, Director Amy L. Ladd sold 500 shares of the business’s stock in a transaction that occurred on Tuesday, April 28th. The shares were sold at an average price of $473.46, for a total value of $236,730.00. Following the completion of the transaction, the director owned 239 shares of the company’s stock, valued at $113,156.94. The trade was a 67.66% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Iman Jeddi sold 5,625 shares of the business’s stock in a transaction that occurred on Monday, June 1st. The stock was sold at an average price of $420.55, for a total transaction of $2,365,593.75. Following the completion of the transaction, the senior vice president directly owned 6,463 shares of the company’s stock, valued at approximately $2,718,014.65. This represents a 46.53% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 7,169 shares of company stock valued at $3,059,135. 0.60% of the stock is owned by corporate insiders.
More Intuitive Surgical News
- Positive Sentiment: Analysts and market watchers still point to solid underlying business momentum, including strong da Vinci procedure growth, continued da Vinci 5 adoption, and expectations that Intuitive Surgical could beat Q2 earnings estimates. Article Title
- Positive Sentiment: Some commentary says the recent weakness reflects investor sentiment and valuation concerns more than company fundamentals, suggesting the long-term growth story remains intact. Article Title
- Neutral Sentiment: The company is heading into its July 16 earnings report, which is keeping traders on the sidelines and increasing volatility ahead of the release. Article Title
- Negative Sentiment: Fresh analyst price-target cuts, including TD Cowen’s reduction to $520 from $585, have reinforced concerns about valuation, competition, international-market challenges, and tariff pressure on margins. Article Title
- Negative Sentiment: The stock also saw unusually heavy put buying and a broader pullback in medtech names, signaling that some investors are positioning defensively ahead of earnings. Article Title
Analysts Set New Price Targets
A number of research firms have recently commented on ISRG. HSBC cut their price target on Intuitive Surgical from $653.00 to $604.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. Evercore set a $430.00 price objective on Intuitive Surgical in a research note on Monday, July 6th. Zacks Research cut Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Monday, March 30th. Truist Financial cut their target price on Intuitive Surgical from $650.00 to $580.00 and set a “buy” rating for the company in a research note on Wednesday, April 15th. Finally, UBS Group reduced their target price on Intuitive Surgical from $570.00 to $550.00 and set a “neutral” rating for the company in a report on Tuesday, March 17th. One research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $566.27.
Check Out Our Latest Research Report on Intuitive Surgical
Intuitive Surgical Stock Down 6.8%
Intuitive Surgical stock opened at $379.50 on Wednesday. Intuitive Surgical, Inc. has a 52 week low of $378.50 and a 52 week high of $603.88. The business has a 50-day simple moving average of $419.65 and a 200 day simple moving average of $471.31. The stock has a market cap of $134.40 billion, a price-to-earnings ratio of 46.00, a PEG ratio of 3.31 and a beta of 1.46.
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last announced its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, topping analysts’ consensus estimates of $2.08 by $0.42. The business had revenue of $2.77 billion for the quarter, compared to analyst estimates of $2.62 billion. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The company’s quarterly revenue was up 23.0% compared to the same quarter last year. During the same period in the prior year, the company earned $1.81 EPS. On average, research analysts anticipate that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current year.
About Intuitive Surgical
Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.
In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.
Featured Articles
- Five stocks we like better than Intuitive Surgical
- Why Fastenal’s Latest Drop Could Be Its Biggest Opportunity Yet
- 3 Overlooked Energy ETFs Delivering Strong Returns and Income
- 3 Space Stocks That Could Outshine SpaceX After Its IPO
- JPMorgan’s Q2 Strength Gives the Stock Rally New Support
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
